Home
/
Development course

2022.7

(Summary description)On July 28, 2022, Hefei Spurui Pharmaceutical Co., Ltd. passed the GMP compliance inspection of Anhui Drug Evaluation and Inspection Center and obtained approval (Wanyao Review [2022] No. 68).

2022.7

(Summary description)On July 28, 2022, Hefei Spurui Pharmaceutical Co., Ltd. passed the GMP compliance inspection of Anhui Drug Evaluation and Inspection Center and obtained approval (Wanyao Review [2022] No. 68).

Information

On July 28, 2022, Hefei Spurui Pharmaceutical Co., Ltd. passed the GMP compliance inspection of Anhui Drug Evaluation and Inspection Center and obtained approval (Wanyao Review [2022] No. 68).

Scan the QR code to read on your phone

Previous: 2022.8
Next: 2022.5
Previous: 2022.8
Next: 2022.5
Previous : 2022.8
Next : 2022.5
Previous : 2022.8
Next : 2022.5

Recommended news

"Venlafaxine hydrochloride sustained release tablets" by Hefei City the first three new product certification

2023-03-29

Hefei Huafang Medicine won the Anhui Provincial Patent Excellence Award

2020-10-22

Hefei Huafang Pharmaceutical's independent research and development project "Key Technology Breakthrough and Industrial Application of Oral Solid Preparations" won the first prize of Anhui Science and Technology Progress Award

2021-04-13

Hefei Huafang Medicine organized special training lectures on "Civil Code"

2020-10-19

The total investment is 30.88 billion yuan! Signing text of the first batch of projects in the high-tech block of Hefei area of ​​Anhui Pilot Free Trade Zone: [Large] [Middle]

2020-10-19

Huafang Pharmceutical Sciences

Hotline：0551-65551391

Fax：0551-65336396

Add： Building D-5, Technology Industrial Park, 168 Xiangzhang Avenue, National High-tech Zone, Hefei City

Huafang

Wechat

Huafang

Mobile

Copyright © Huafang Pharmceutical

Verification 皖ICP备10206584号-1
Sitemap
Market
Job
Team spirit
Honor
Public welfare
Company News
Copyright